Pronounced differences in inhibition potency of lactone and non-lactone compounds for mouse and human coumarin 7-hydroxylases (CYP2A5 and CYP2A6)

References

• Arno, A., 1978, A simple and sensitive assay of 7-ethoxycoumarin deethylation. Analytical Biochemistry, 85, 488–491.
   PubMedGoogle Scholar
• ASIKAINEN, J., PASANEN, M. and JUVONEN, R. 0., 1996, Inhibition of mice coumarin 7-hydroxylase bu undecanoic a-lacton, benzoxazole and 2H-pyran-2-one. Experimental and Toxicologic Pathology, 48 (suppl. II), 13–17.
   Google Scholar
• CHANG, T. K. H. and WAXIVIAN, D. J., 1996, The CYP2A subfamily. In C. Ioannides (ed.), Cytochromes P450: Metabolic and Toxicological Aspects (Boca Raton: CRC Press), pp. 99–134.
   Google Scholar
• DING, S., LAKE, B. G., FRIEDBERG, T. and WOLF, C. R., 1995, Expression and alternative splicing of the cytochrome P-450 CYP2A7. Biochemical Journal, 306, 161-1 66.
   Google Scholar
• DRAPER, A. J., MADAN, A. and PARKINSON A., 1997, Inhibition of coumarin 7-hydroxylase activity in human liver microsomes. Archives of Biochemistry and Biophysics, 341, 47–61.
   Google Scholar
• GOTOH, 0., 1992, Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. Journal of Biological Chemistry, 267, 83–90.
   Google Scholar
• HALPERT J. R. and HE, Y., 1993, Engineering of cytochrome P45 02B1 specificity: conversion of an androgen 16/3-hydroxylase to a 15a-hydroxylase. Journal of Biological Chemistry, 268, 445 31157.HONICAKOSKI, P. and NEGISHI, M., 1997, The structure, function and regulation of cytochrome P4502A enzymes. Drug metabolism reviews, 29, 977–996.
   Google Scholar
• JUVONEN, R. 0., IWASAKI, M. and NEGIsru, M., 1991, Structural function of residue-209 in coumarin 7-hydroxylase (P45 Ocoh). Enzyme-kinetic studies and site-directed mutagenesis. Journal of Biological Chemistry, 266, 16431–16435.
   Google Scholar
• JUVONEN, R. 0., KAIPAINEN, P. K. and LANG, MA., 1985, Selective induction of coumarin 7-hydroxylase by pyrazole in D2 mice. European Journal of Biochemistry, 152, 3–8.
   Google Scholar
• JUVONEN, R. 0., SHKUMATOV, V. M. and LANG, M. A., 1988, Purification and characterization of a liver microsomal cytochrome P-450 isoenzyme with a high affinity and metabolic capacity for coumarin from pyrazole-treated D2 mice. European Journal of Biochemistry, 171, 205–211.
   Google Scholar
• KIMONEN, T., JUVONEN, R. 0., ALHAVA, E. and PASANEN, M., 1995, The inhibition of CYP enzymes in mouse and human liver by pilocarpine. British Journal of Pharmacology, 114, 832–836.
   Google Scholar
• KINONEN, T., PASANEN, M., GYNniER, J., Poso, A., JARVINEN, T., ALHAVA, E. and JUVONEN, R. 0., 1995, Competitive inhibition of coumarin 7-hydroxylation by pilocrpine and its interaction with mouse CYP 2A5 and human CYP 2A6. British Journal of Pharmacology, 116,2625–2630.
   Google Scholar
• LANG, M. A., JUVONEN, R. 0., JARVINEN, P., HONICAKOSKI, P. and RAUNIO, H., 1989, Mouse liver P450coh: genetic regulation of the pyrazole-inducible enzyme and comparison with other P450 isoenzymes. Archives of Biochemistry and Biophysics, 271, 139–148.
   Google Scholar
• LANG, M. A. and NEBERT, D. W., 1981, Structural gene products of the Ah locus. Evidence for many unique P-450-mediated monooxygenase activities reconstituted from 3-methylcholantrene-treated C57BL/6N mouse liver microsomes. Journal of Biological Chemistry, 256, 12058–12067.
   PubMedGoogle Scholar
• LINDBERG, R. L. P. and NEGISHI, M., 1989, Alteration of mouse cytochrome P45 Ocoh substrate specificity by mutation of a single amino-acid residue. Nature, 339, 632–634.
   Google Scholar
• MAENPA, J., SIGUSCH, H., RAUNIO, H., SYNGELMA7, T., VUORELA, P., VUORELA, H. and PELKONEN, 0., 1993, Differential inhibition of coumarin hydroxylase activity in mouse and human liver microsomes. Biochemical Pharmacology, 45, 1035–1042.
   Google Scholar
• MATSUNAGA, E., ZEUGIN, T., ZANGER, U. M., ÃOYAMA, T., MEYER, U. A. and GONZALEZ, F. J., 1990, Sequence requirements for cytochrome P-450I1D1 catalytic activity: a single amino acid change (ILE380Phe specifically decreases limax of the enzyme for bufuralol but not debrisoquine hydroxylation. Journal of Biological Chemistry, 265, 17197–17201.
   Google Scholar
• MESSINA, E. S., TYNDALE, R. F. and SELLERS, E. M., 1997, A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. Journal of Pharmacology and Experimental Therapeutics, 282, 1608–1614.
   PubMed Web of Science ®Google Scholar
• MILES, J. S., MCLARE, A. W., FORRES1ER, L. M., GLANCEY, M. J., LANG, M. A. and WOLF, C. R., 1990, Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. Biochemical Journal, 267, 365–371.
   Google Scholar
• NEGISHI M., LINDBERG, R., BURKHART, B., ICHIKAWA, T., HONKAKOSKI, P. and LANG, M., 1989, Mouse steroid 15alpha-hydroxylase gene family: identification of type II P-450(15)alpha as coumarin 7-hydroxylase. Biochemistry, 28, 4169–4172.
   Google Scholar
• PELKONEN 0., RAUNIO, H., RAUTIO, A., PASANEN, M. and LANG, M. A., 1997, The metabolism of coumarin. In Coumarins: Biology, Applications and Mode of Action (Chichester: John Wiley), pp. 67–92.
   Google Scholar
• RALTNIO, H., JUVONEN, R., PASANEN M., PELKONEN 0., PAAKK(5, P. and Sorm, Y., 1998, Cytochrome P4502A6 (CYP2A6) expression in human hepatocellular carcinoma. Hepatology, 27, 427–432.
   Google Scholar
• RAUNIO, H., VALTONEN, J., HONKAKOSKI, P., LANG, M. A., STAHLBERG, M., KA1RALUOMA, M. A., RAUTIO, A., PASANEN, M. and PELKONEN 0., 1990, Immunochemical detection of human liver cytochrome P450 forms related to phenobarbital-inducible forms in the mouse. Biochemical Pharmacology, 40, 2503–2509.
   Google Scholar
• SMITH, P. K., KROHN, R. I., HERMANSON, G. T., MALLIA, A. K., GARTNER, F. H., PROVENZANO, M. D., FUJIMOTO, E. K., GOEKE, N. M., OLSON, B. J. and KLENK, D. C., 1985, Measurement of protein using bicinchonic acid. Analytical Biochemistry, 150, 76–85.
   PubMed Web of Science ®Google Scholar
• SRAUB, P., LLOYD, M., JOHNSON, E. F. and KEMPER, B., 1994, Differential effects of mutation in substrate recognition site 1 of cytochrome P450 2C2 on lauric acid and progesterone hydroxylation. Biochemistry, 33, 8029–8034.
   PubMedGoogle Scholar
• YAMANO S., TATSUNO, J. and GONZALEZ, F. J., 1990, The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry, 29, 1322–1329.
   Google Scholar
• YUN, C. H., SHIMADA, T. and GUENGERICH, F. P., 1991, Purification and characterization of human liver microsomal cytochrome P450 of the HA subfamily from human liver microsomes. Molecular Pharmacology, 40, 679.
   PubMed Web of Science ®Google Scholar